Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
IR and corporate presentations for individual investors
Launch date28 August 2026 (scheduled); the event will be held from 28 to 29 August 2026
Relationship between the counterparty and the company
K Pharma,Inc.4896
Relationship with the Company
Exhibition at the IR event and relationship with the event organizers
CounterpartyNikkei Inc.; Japan Exchange Group, Inc.
Only the fact that Nihon Keizai Shimbun, Inc. and Japan Exchange Group, Inc. are the event organizers is disclosed. Other details are not disclosed.
Location (as indicated in this announcement)
Tokyo Big Sight (3-11-1 Ariake, Koto-ku, Tokyo), South Halls 3 and 4
Exhibition booth number: 047
Offering price
Admission fee: Free
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty | Nikkei Inc.; Japan Exchange Group, Inc. |
| Counterparty overview | Only the fact that Nihon Keizai Shimbun, Inc. and Japan Exchange Group, Inc. are the event organizers is disclosed. Other details are not disclosed. |
| Relationship with the Company | Exhibition at the IR event and relationship with the event organizers |
| Offering price | Admission fee: Free |
| Launch date | 28 August 2026 (scheduled); the event will be held from 28 to 29 August 2026 |
| Applicable area | IR and corporate presentations for individual investors |
| Location | Tokyo Big Sight (3-11-1 Ariake, Koto-ku, Tokyo), South Halls 3 and 4 |
| Location scale | Exhibition booth number: 047 |
Items this document does not state (10)
Names of Products / Services CoveredContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide an opportunity to explain the company's corporate philosophy, business progress and growth strategy directly to individual investors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.